Table 13.
Uncertain indications (median score 4–6)
| Indication | Appropriateness criteria (median score) | |
|---|---|---|
| Detection of CAD: symptomatic—evaluation of chest pain syndrome | ||
| 2 | Intermediate pre-test probability of CAD | U (4) |
| ECG interpretable AND able to exercise | ||
| 4 | High pre-test probability of CAD | U (6) |
| Detection of CAD: symptomatic—acute chest pain | ||
| 6 | Low pre-test probability of CAD | U (4) |
| No ECG changes and serial enzymes negative | ||
| 7 | Intermediate pre-test probability of CAD | U (5) |
| No ECG changes and serial enzymes negative | ||
| 8 | High pre-test probability of CAD | U (5) |
| No ECG changes and serial enzymes negative | ||
| Detection of CAD: asymptomatic—asymptomatic | ||
| 11 | Moderate CHD risk (Framingham) | U (4) |
| 12 | High CHD risk (Framingham) | U (6) |
| Risk Assessment: general population—asymptomatic (use of coronary MRA) | ||
| 15 | High CHD risk (Framingham) | U (5) |
| Detection of CAD with prior test results—evaluation of chest pain syndrome | ||
| 17 | Evidence of moderate to severe ischemia on stress test (exercise, perfusion, or stress echo) | U (5) |
| Risk Assessment with prior test results—asymptomatic | ||
| 19 | Equivocal stress test (exercise, stress SPECT, or stress echo) | U (6) |
| Intermediate CHD risk (Framingham) | ||
| CAD detection in pediatric patients with kawasaki disease—asymptomatic | ||
| 21 | No previous definitive test (invasive angiography, MRCA or CTCA) available | U (5) |
| Risk assessment: preoperative evaluation for non-cardiac surgery | ||
| Intermediate- or high-risk surgery | ||
| 26 | Intermediate perioperative risk | U (5) |
| Risk assessment: preoperative evaluation for cardiac surgery or endovascular intervention—preoperative evaluation | ||
| 27 | Use of MRI for CAD evaluation before valve surgery | U (6) |
| 29 | Evaluation of complex lesions before PCI (i.e., chronic total occlusions, bifurcation lesions) | U (5) |
| Detection of CAD: post-revascularization (PCI or CABG)—evaluation of chest pain syndrome | ||
| 30 | Evaluation of bypass grafts and coronary anatomy | U (5) |
| 31 | History of percutaneous revascularization with stents | U (4) |
| Detection of CAD: post-revascularization (PCI or CABG)—asymptomatic | ||
| 32 | Evaluation of bypass grafts and coronary anatomy | U (4) |
| Less than 5 years after CABG | ||
| 33 | Evaluation of bypass grafts and coronary anatomy | U (4) |
| Greater than or equal to 5 years after CABG | ||